Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Paradiso

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Primary tumours neoangiogenesis and P53 expression in oral carcinoma patientsL Grammatica, S Piepoli, C D'Auria, et al.
Oncology|March 1, 1993
Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancerA Paradiso, V Ventrella, G Farchi, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapiesG Ranieri, C D Gadaleta, R Patruno, et al.
International Journal of Oncology|October 28, 1999
In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2[E-HN=C(OMe)Me]2]M Coluccia, A Nassi, A Boccarelli, et al.
British Journal of Cancer|March 10, 2001
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancerA Paradiso, G Simone, M D Lena, et al.
Breast Cancer Research and Treatment|January 1, 1993
Quantitative immunohistochemical determination of cathepsin-D and its relation with other variablesS Veneroni, M G Daidone, G Di Fronzo, et al.
Pathologica|July 1, 1991
[Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma]G Simone, A Paradiso, R Cirillo, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|July 23, 2003
Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targetsE Guastamacchia, F Resta, A Mangia, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activityM Correale, A Paradiso, I Abbate, et al.
Drugs|January 1, 1993
Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancerA Paradiso, A Mangia, A Barletta, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Primary tumours neoangiogenesis and P53 expression in oral carcinoma patientsL Grammatica, S Piepoli, C D'Auria, et al.
Oncology|March 1, 1993
Mammographic aspect, cell kinetics and hormone receptor status of operable breast cancerA Paradiso, V Ventrella, G Farchi, et al.
Critical Reviews in Oncology/Hematology|April 9, 2013
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapiesG Ranieri, C D Gadaleta, R Patruno, et al.
International Journal of Oncology|October 28, 1999
In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2[E-HN=C(OMe)Me]2]M Coluccia, A Nassi, A Boccarelli, et al.
British Journal of Cancer|March 10, 2001
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancerA Paradiso, G Simone, M D Lena, et al.
Breast Cancer Research and Treatment|January 1, 1993
Quantitative immunohistochemical determination of cathepsin-D and its relation with other variablesS Veneroni, M G Daidone, G Di Fronzo, et al.
Pathologica|July 1, 1991
[Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma]G Simone, A Paradiso, R Cirillo, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|July 23, 2003
Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targetsE Guastamacchia, F Resta, A Mangia, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activityM Correale, A Paradiso, I Abbate, et al.
Drugs|January 1, 1993
Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancerA Paradiso, A Mangia, A Barletta, et al.
Pageof 18